Literature DB >> 34344351

Decreased human respiratory syncytial virus activity during the COVID-19 pandemic in Japan: an ecological time-series analysis.

Keita Wagatsuma1, Iain S Koolhof2, Yugo Shobugawa3, Reiko Saito4.   

Abstract

BACKGROUND: Non-pharmaceutical interventions (NPIs), such as sanitary measures and travel restrictions, aimed at controlling the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), may affect the transmission dynamics of human respiratory syncytial virus (HRSV). We aimed to quantify the contribution of the sales of hand hygiene products and the number of international and domestic airline passenger arrivals on HRSV epidemic in Japan.
METHODS: The monthly number of HRSV cases per sentinel site (HRSV activity) in 2020 was compared with the average of the corresponding period in the previous 6 years (from January 2014 to December 2020) using a monthly paired t-test. A generalized linear gamma regression model was used to regress the time-series of the monthly HRSV activity against NPI indicators, including sale of hand hygiene products and the number of domestic and international airline passengers, while controlling for meteorological conditions (monthly average temperature and relative humidity) and seasonal variations between years (2014-2020).
RESULTS: The average number of monthly HRSV case notifications in 2020 decreased by approximately 85% (p < 0.001) compared to those in the preceding 6 years (2014-2019). For every average ¥1 billion (approximately £680,000/$9,000,000) spent on hand hygiene products during the current month and 1 month before there was a 0.29% (p = 0.003) decrease in HRSV infections. An increase of average 1000 domestic and international airline passenger arrivals during the previous 1-2 months was associated with a 3.8 × 10- 4% (p < 0.001) and 1.2 × 10- 3% (p < 0.001) increase in the monthly number of HRSV infections, respectively.
CONCLUSIONS: This study suggests that there is an association between the decrease in the monthly number of HRSV cases and improved hygiene and sanitary measures and travel restrictions for COVID-19 in Japan, indicating that these public health interventions can contribute to the suppression of HRSV activity. These findings may help in public health policy and decision making.
© 2021. The Author(s).

Entities:  

Keywords:  COVID-19; Epidemics; HRSV; NPIs; SARS-CoV-2

Year:  2021        PMID: 34344351     DOI: 10.1186/s12879-021-06461-5

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


  58 in total

1.  Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe.

Authors:  Seth Flaxman; Swapnil Mishra; Axel Gandy; H Juliette T Unwin; Thomas A Mellan; Helen Coupland; Charles Whittaker; Harrison Zhu; Tresnia Berah; Jeffrey W Eaton; Mélodie Monod; Azra C Ghani; Christl A Donnelly; Steven Riley; Michaela A C Vollmer; Neil M Ferguson; Lucy C Okell; Samir Bhatt
Journal:  Nature       Date:  2020-06-08       Impact factor: 49.962

Review 2.  The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates.

Authors:  Natalie I Mazur; Deborah Higgins; Marta C Nunes; José A Melero; Annefleur C Langedijk; Nicole Horsley; Ursula J Buchholz; Peter J Openshaw; Jason S McLellan; Janet A Englund; Asuncion Mejias; Ruth A Karron; Eric Af Simões; Ivana Knezevic; Octavio Ramilo; Pedro A Piedra; Helen Y Chu; Ann R Falsey; Harish Nair; Leyla Kragten-Tabatabaie; Anne Greenough; Eugenio Baraldi; Nikolaos G Papadopoulos; Johan Vekemans; Fernando P Polack; Mair Powell; Ashish Satav; Edward E Walsh; Renato T Stein; Barney S Graham; Louis J Bont
Journal:  Lancet Infect Dis       Date:  2018-06-18       Impact factor: 25.071

3.  Ranking the effectiveness of worldwide COVID-19 government interventions.

Authors:  Nina Haug; Lukas Geyrhofer; Alessandro Londei; Elma Dervic; Amélie Desvars-Larrive; Vittorio Loreto; Beate Pinior; Stefan Thurner; Peter Klimek
Journal:  Nat Hum Behav       Date:  2020-11-16

Review 4.  Respiratory syncytial virus infection and bronchiolitis.

Authors:  Giovanni Piedimonte; Miriam K Perez
Journal:  Pediatr Rev       Date:  2014-12

5.  Effect of non-pharmaceutical interventions to contain COVID-19 in China.

Authors:  Shengjie Lai; Nick W Ruktanonchai; Liangcai Zhou; Olivia Prosper; Wei Luo; Jessica R Floyd; Amy Wesolowski; Mauricio Santillana; Chi Zhang; Xiangjun Du; Hongjie Yu; Andrew J Tatem
Journal:  Nature       Date:  2020-05-04       Impact factor: 49.962

6.  The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections.

Authors:  Rachel E Baker; Sang Woo Park; Wenchang Yang; Gabriel A Vecchi; C Jessica E Metcalf; Bryan T Grenfell
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-09       Impact factor: 11.205

7.  Decreased Influenza Incidence under COVID-19 Control Measures, Singapore.

Authors:  Roy Jiunn Jye Soo; Calvin J Chiew; Stefan Ma; Rachael Pung; Vernon Lee
Journal:  Emerg Infect Dis       Date:  2020-04-27       Impact factor: 6.883

8.  Collateral Benefit of COVID-19 Control Measures on Influenza Activity, Taiwan.

Authors:  Shu-Chen Kuo; Shu-Man Shih; Li-Hsin Chien; Chao A Hsiung
Journal:  Emerg Infect Dis       Date:  2020-04-27       Impact factor: 6.883

9.  Clinical characteristics, predictors, and performance of case definition-Interim results from the WHO global respiratory syncytial virus surveillance pilot.

Authors:  Siddhivinayak Hirve; Nigel Crawford; Rakhee Palekar; Wenqing Zhang
Journal:  Influenza Other Respir Viruses       Date:  2019-10-31       Impact factor: 4.380

10.  Global burden of acute lower respiratory infection associated with human metapneumovirus in children under 5 years in 2018: a systematic review and modelling study.

Authors:  Xin Wang; You Li; Maria Deloria-Knoll; Shabir A Madhi; Cheryl Cohen; Asad Ali; Sudha Basnet; Quique Bassat; W Abdullah Brooks; Malinee Chittaganpitch; Marcela Echavarria; Rodrigo A Fasce; Doli Goswami; Siddhivinayak Hirve; Nusrat Homaira; Stephen R C Howie; Karen L Kotloff; Najwa Khuri-Bulos; Anand Krishnan; Marilla G Lucero; Socorro Lupisan; Ainara Mira-Iglesias; David P Moore; Cinta Moraleda; Marta Nunes; Histoshi Oshitani; Betty E Owor; Fernando P Polack; Katherine L O'Brien; Zeba A Rasmussen; Barbara A Rath; Vahid Salimi; J Anthony G Scott; Eric A F Simões; Tor A Strand; Donald M Thea; Florette K Treurnicht; Linda C Vaccari; Lay-Myint Yoshida; Heather J Zar; Harry Campbell; Harish Nair
Journal:  Lancet Glob Health       Date:  2020-11-26       Impact factor: 26.763

View more
  7 in total

Review 1.  Collateral Impact of Public Health and Social Measures on Respiratory Virus Activity during the COVID-19 Pandemic 2020-2021.

Authors:  Chiara Achangwa; Huikyung Park; Sukhyun Ryu; Moo-Sik Lee
Journal:  Viruses       Date:  2022-05-17       Impact factor: 5.818

2.  Decreased Antibiotic Consumption Coincided with Reduction in Bacteremia Caused by Bacterial Species with Respiratory Transmission Potential during the COVID-19 Pandemic.

Authors:  Vincent Chi-Chung Cheng; Shuk-Ching Wong; Simon Yung-Chun So; Jonathan Hon-Kwan Chen; Pui-Hing Chau; Albert Ka-Wing Au; Kelvin Hei-Yeung Chiu; Xin Li; Patrick Ip; Vivien Wai-Man Chuang; David Christopher Lung; Cindy Wing-Sze Tse; Rodney Allan Lee; Kitty Sau-Chun Fung; Wing-Kin To; Raymond Wai-Man Lai; Tak-Lun Que; Janice Yee-Chi Lo; Kwok-Yung Yuen
Journal:  Antibiotics (Basel)       Date:  2022-05-31

3.  Epidemiological Consequences of Viral Interference: A Mathematical Modeling Study of Two Interacting Viruses.

Authors:  Lubna Pinky; Hana M Dobrovolny
Journal:  Front Microbiol       Date:  2022-03-11       Impact factor: 5.640

4.  Respiratory syncytial virus pneumonia in an adult cord blood transplant recipient during the SARS-CoV-2 outbreak.

Authors:  Takaaki Konuma; Masamichi Isobe; Seiko Kato; Satoshi Takahashi; Yasuhito Nannya
Journal:  EJHaem       Date:  2021-12-04

Review 5.  Impact of COVID-19 on the Changing Patterns of Respiratory Syncytial Virus Infections.

Authors:  Ishan Garg; Rahul Shekhar; Abu Baker Sheikh; Suman Pal
Journal:  Infect Dis Rep       Date:  2022-07-24

6.  Was the Reduction in Seasonal Influenza Transmission during 2020 Attributable to Non-Pharmaceutical Interventions to Contain Coronavirus Disease 2019 (COVID-19) in Japan?

Authors:  Keita Wagatsuma; Iain S Koolhof; Reiko Saito
Journal:  Viruses       Date:  2022-06-28       Impact factor: 5.818

Review 7.  Clinical and biological consequences of respiratory syncytial virus genetic diversity.

Authors:  Estefany Rios Guzman; Judd F Hultquist
Journal:  Ther Adv Infect Dis       Date:  2022-10-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.